Theravance Biopharma, Inc. (TBPH)
18.27
-0.44
(-2.35%)
USD |
NASDAQ |
Jan 02, 10:44
Theravance Biopharma Research and Development Expense (Annual): 36.04M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Corcept Therapeutics, Inc. | 246.89M |
| Perspective Therapeutics, Inc. | 39.33M |
| Skye Bioscience, Inc. | 18.70M |
| FibroGen, Inc. | 95.69M |
| Myomo, Inc. | 4.772M |